Unimolecular Sonoafterglow Probes for Biomarker-Activated Imaging of Senescent Cancer Cells.
The para-substituted luminophore is further developed into a β-galactosidase-activatable probe, enabling real-time, longitudinal imaging of DOX-induced senescent tumor in vivo and offers a versatile platform for biomarker-activatable sonoafterglow imaging.